Skip to content
Home/Companies/Biotech/Myricx Bio
MB

Myricx Bio

Biotech·UK·Active·4yr hold

Myricx Bio is a healthcare / biotech company, headquartered in United Kingdom.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Myricx Bio?

Myricx Bio is currently owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage), since 2022. Across its history, Myricx Bio has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare / Biotech

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Sofinnova Partners since 2022.
Co-invest · 2 holders · 2022 · present
Sofinnova Partners
Sofinnova PartnersActive
2022 · present · Sofinnova Capital X · 2021 · Life Sciences VC
MOIC
–
Abingworth
AbingworthExited 2026
2024 · 2026 · Abingworth Bioventures 8 · 2021 · Life Sciences VC
Trade Sale · to
MOIC
–

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals
Active
BiotechGermany· 2023
Freya Biosciences
Active
BiotechDenmark· 2023
May Health
Active
MedTechFrance· 2023
Nuage Therapeutics
Active
BiotechSpain· 2023
T-Therapeutics
Active
BiotechUK· 2023
Catamaran Bio
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings